321
Participants
Start Date
September 1, 2024
Primary Completion Date
February 1, 2026
Study Completion Date
February 1, 2028
Paclitaxel drug-coated balloons
Patients will be randomized to Paclitaxel drug-coated balloons, Sirolimus drug-coated balloons or standard therapy with new generation drug-eluting stent
Sirolimus drug-coated balloons
Patients will be randomized to Paclitaxel drug-coated balloons, Sirolimus drug-coated balloons or standard therapy with new generation drug-eluting stent
New generation drug-eluting stent
Patients will be randomized to Paclitaxel drug-coated balloons, Sirolimus drug-coated balloons or standard therapy with new generation drug-eluting stent
Fondazione Ricerca e Innovazione Cardiovascolare, Milan
First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland, Gdansk
Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland, Krakow
Second Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland, Krakow
Department of Cardiology, Copper Health Centre (MCZ), Lubin
Clinical Department of Interventional Cardiology, Medical University of Lublin, Lublin
Department of Cardiology, Poznan University of Medical Sciences, Poznan
Department of Cardiology, The Ministry of Internal Affairs and Administration Hospital, Rzeszow, Rzeszów
Department of Cardiology and Internal Diseases, Military Institute of Medicine, Warsaw
Department of Invasive Cardiology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw
Department of Cardiology, Wałbrzych
Centre for Heart Disease, University Hospital Wroclaw Department of Heart Disease, Wroclaw Medical University, Wroclaw
Third Department of Cardiology, Medical University of Katowice, Zabrze
Tan Tock Seng Hospital, Singapore
Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland, Katowice
Fondazione Ricerca e Innovazione Cardiovascolare ETS
OTHER